Copy number variations and human genetic disease

Current Opinion in Pediatrics

Volumn 26, Issue 6, 2014, Pages 646-652

  Mikhail, Fady M ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Array comparative genomic hybridization; Chromosomal microarray; Copy number variation; Microdeletion; Microduplication; Segmental duplications

Indexed keywords

COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; DISEASE ASSOCIATION; DNA POLYMORPHISM; DNA REPLICATION; DNA SYNTHESIS; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC VARIABILITY; HUMAN; MUTATION RATE; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SEGMENTAL DUPLICATION; GENETICS; HUMAN GENOME; MEDICAL GENETICS; PROCEDURES;

DNA COPY NUMBER VARIATIONS; GENETIC DISEASES, INBORN; GENETICS, MEDICAL; GENOME, HUMAN; HUMANS;

EID: 84921890577     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0000000000000142     Document Type: Review

References (62)

1. Lupski JR. Genomic rearrangements and sporadic disease. Nat Genet 2007; 39: S43-S47.
2. Campbell CD, Eichler EE. Properties and rates of germline mutations in humans. Trends Genet 2013; 29: 575-584.
3. Pinkel D, Segraves R, Sudar D, et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998; 20: 207-211.
4. Cooper GM, Zerr T, Kidd JM, et al. Systematic assessment of copy number variant detection via genome-wide SNP genotyping. Nat Genet 2008; 40: 1199-1203.
5. McCarroll SA, Kuruvilla FG, Korn JM, et al. Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet 2008; 40: 1166-1174.
6. Sudmant PH, Kitzman JO, Antonacci F, et al. Diversity of human copy number variation and multicopy genes. Science 2010; 330: 641-646.
7. Gu W, Zhang F, Lupski JR. Mechanisms for human genomic rearrangements. Pathogenetics 2008; 1: 4.
8. Bailey JA, Yavor AM, Massa HF, et al. Segmental duplications: organization and impact within the current human genome project assembly. Genome Res 2001; 11: 1005-1017.
9. Weterings E, van Gent DC. The mechanism of nonhomologous end-joining: a synopsis of synapsis. DNA Repair (Amst) 2004; 3: 1425-1435.
10. Lee JA, Carvalho CM, Lupski JR. A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders. Cell 2007; 131: 1235-1247.
11. Zhang F, Khajavi M, Connolly AM, et al. The DNA replication FoSTeS/MMBIR mechanism can generate genomic, genic and exonic complex rearrangements in humans. Nat Genet 2009; 41: 849-853.
12. Lupski JR, Wise CA, Kuwano A, et al. Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A. Nat Genet 1992; 1: 29-33.
13. Kleinjan DA, vanHeyningen V. Long-range control of gene expression: emerging mechanisms and disruption in disease. Am J Hum Genet 2005; 76: 8-32.
14. Lee JA, Madrid RE, Sperle K, et al. Spastic paraplegia type 2 associated with axonal neuropathy and apparent PLP1 position effect. Ann Neurol 2006; 59: 398-403.
15. Smyk M, Berg JS, Pursley A, et al. Male-to-female sex reversal associated with an approximately 250 kb deletion upstream of NR0B1 (DAX1). Hum Genet 2007; 122: 63-70.
16. Dathe K, Kjaer KW, Brehm A, et al. Duplications involving a conserved regulatory element downstream of BMP2 are associated with brachydactyly type A2. Am J Hum Genet 2009; 84: 483-492.
17. Stankiewicz P, Lupski JR. Structural variation in the human genome and its role in disease. Annu Rev Med 2010; 61: 437-455.
18. Lupski JR, Stankiewicz P. Genomic disorders: molecular mechanisms for rearrangements and conveyed phenotypes. PLoS Genet 2005; 1: e49.
19. Itsara A, Cooper GM, Baker C, et al. Population analysis of large copy number variants and hotspots of human genetic disease. Am J Hum Genet 2009; 84: 148-161.
20. Shaikh TH, Gai X, Perin JC, et al. High-resolution mapping and analysis of copy number variations in the human genome: a data resource for clinical and research applications. Genome Res 2009; 19: 1682-1690.
21. 1000 Genomes Project Consortium. Abecasis GR, Auton A, Brooks LD, et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012; 491: 56-65.
22. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010; 86: 749-764.
23. Manning M, Hudgins L. Professional Practice and Guidelines Committee. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 2010; 12: 742-745.
24. Cuscó I, Corominas R, Bayés M, et al. Copy number variation at the 7q11. 23 segmental duplications is a susceptibility factor for the Williams-Beuren syndrome deletion. Genome Res 2008; 18: 683-694.
25. Osborne LR, Li M, Pober B, et al. A 1. 5 million-base pair inversion polymorphism in families with Williams-Beuren syndrome. Nat Genet 2001; 29: 321-325.
26. Giglio S, Broman KW, Matsumoto N, et al. Olfactory receptor-gene clusters, genomic-inversion polymorphisms, and common chromosome rearrangements. Am J Hum Genet 2001; 68: 874-883.
27. Gimelli G, Pujana MA, Patricelli MG, et al. Genomic inversions of human chromosome 15q11-q13 in mothers of Angelman syndrome patients with class II (BP2/3) deletions. Hum Mol Genet 2003; 12: 849-858.
28. Antonacci F, Kidd JM, Marques-Bonet T, et al. Characterization of six human disease-associated inversion polymorphisms. Hum Mol Genet 2009; 18: 2555-2566.
29. Stefansson H, Helgason A, Thorleifsson G, et al. A common inversion under selection in Europeans. Nat Genet 2005; 37: 129-137.
30. Zody MC, Jiang Z, Fung HC, et al. Evolutionary toggling of the MAPT 17q21. 31 inversion region. Nat Genet 2008; 40: 1076-1083.
31. Koolen DA, Vissers LE, Pfundt R, et al. A new chromosome 17q21. 31 microdeletion syndrome associated with a common inversion polymorphism. Nat Genet 2006; 38: 999-1001.
32. Kidd JM, Cooper GM, Donahue WF, et al. Mapping and sequencing of structural variation from eight human genomes. Nature 2008; 453: 56-64.
33. Antonacci F, Kidd JM, Marques-Bonet T, et al. A large and complex structural polymorphism at 16p12. 1 underlies microdeletion disease risk. Nat Genet 2010; 42: 745-750.
34. Girirajan S, Eichler EE. Phenotypic variability and genetic susceptibility to genomic disorders. Hum Mol Genet 2010; 19: R176-R187.
35. Cooper GM, Coe BP, Girirajan S, et al. A copy number variation morbidity map of developmental delay. Nat Genet 2011; 43: 838-846.
36. Kaminsky EB, Kaul V, Paschall J, et al. An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genet Med 2011; 13: 777-784.
37. Girirajan S, Rosenfeld JA, Cooper GM, et al. A recurrent 16p12. 1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet 2010; 42: 203-209.
38. Stefansson H, Meyer-Lindenberg A, Steinberg S, et al. CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature 2014; 505: 361-366.
39. Shao L, Shaw CA, Lu XY, et al. Identification of chromosome abnormalities in subtelomeric regions by microarray analysis: a study of 5,380 cases. Am J Med Genet A 2008; 146A: 2242-2251.
40. Marshall CR, Noor A, Vincent JB, et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008; 82: 477-488.
41. Kirov G, Rujescu D, Ingason A, et al. Neurexin 1 (NRXN1) deletions in schizophrenia. Schizophr Bull 2009; 35: 851-854.
42. Vrijenhoek T, Buizer-Voskamp JE, van der Stelt I, et al. Recurrent CNVs disrupt three candidate genes in schizophrenia patients. Am J Hum Genet 2008; 83: 504-510.
43. Pinto D, Delaby E, Merico D, et al. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am J Hum Genet 2014; 94: 677-694.
44. Krumm N, O'Roak BJ, Shendure J, et al. A de novo convergence of autism genetics and molecular neuroscience. Trends Neurosci 2014; 37: 95-105.
45. Girirajan S, Brkanac Z, Coe BP, et al. Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genet 2011; 7: e1002334.
46. Girirajan S, Eichler EE. De novo CNVs in bipolar disorder: recurrent themes or new directions? Neuron 2011; 72: 885-887.
47. Coe BP, Girirajan S, Eichler EE. A genetic model for neurodevelopmental disease. Curr Opin Neurobiol 2012; 22: 829-836.
48. Bailey JA, Gu Z, Clark RA, et al. Recent segmental duplications in the human genome. Science 2002; 297: 1003-1007.
49. Locke DP, Sharp AJ, McCarroll SA, et al. Linkage disequilibrium and heritability of copy-number polymorphisms within duplicated regions of the human genome. Am J Hum Genet 2006; 79: 275-290.
50. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature 2006; 444: 444-454.
51. Sharp AJ, Locke DP, McGrath SD, et al. Segmental duplications and copy-number variation in the human genome. Am J Hum Genet 2005; 77: 78-88.
52. Bhattacharya T, Stanton J, Kim EY, et al. CCL3L1 and HIV/AIDS susceptibility. Nat Med 2009; 15: 1112-1115.
53. Field SF, Howson JM, Maier LM, et al. Experimental aspects of copy number variant assays at CCL3L1. Nat Med 2009; 15: 1115-1117.
54. Gonzalez E, Kulkarni H, Bolivar H, et al. The influence of CCL3L1 genecontaining segmental duplications on HIV-1/AIDS susceptibility. Science 2005; 307: 1434-1440.
55. Kidd JM, Newman TL, Tuzun E, et al. Population stratification of a common APOBEC gene deletion polymorphism. PLoS Genet 2007; 3: e63.
56. Campbell CD, Sampas N, Tsalenko A, et al. Population-genetic properties of differentiated human copy-number polymorphisms. Am J Hum Genet 2011; 88: 317-332.
57. Wellcome Trust Case Control Consortium. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 2010; 464: 713-720.
58. Fellermann K, Stange DE, Schaeffeler E, et al. A chromosome 8 genecluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 2006; 79: 439-448.
59. Hollox EJ, Huffmeier U, Zeeuwen PL, et al. Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 2008; 40: 3-25.
60. Fanciulli M, Norsworthy PJ, Petretto E, et al. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet 2007; 39: 721-723.
61. Feldkötter M, Schwarzer V, Wirth R, et al. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 2002; 70: 358-368.
62. Mailman MD, Heinz JW, Papp AC, et al. Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2. Genet Med 2002; 4: 20-26.